Those taking statins were found to have a 12 to 15 percent lowered risk of developing Alzheimer's.
Stains used to lower cholesterol have been linked to lowering the likelihood of developing Alzheimer’s disease according to a new study.
The research reviewed around 400,000 people and found those who took the drug on a regular basis lowered their risk by between 12 and 15 percent.
Despite the amazing findings, many are cautious as to whether it was enough evidence to prove that taking statins can prevent dementia. However, the researchers behind the study hailing from University of Southern California believe there is a connection between cholesterol – which is combated by statins – and beta-amyloid which is linked to dementia. Either that or an anti-inflammatory element of the drug is somehow protecting the brain against the disease.
The results of the study showed the 12 percent decrease in dementia applied to men, while 15 percent of women were protected from developing Alzheimer’s. Participants were of all ethnic and gender groups but surprisingly, black men were not protected at all despite taking statins regularly.
The researchers also looked at the effects of different types of statin. For example, they found that pravastatin and rosuvastatin were particularly associated with a reduced risk of Alzheimer’s in white women.
“The right statin type for the right person at the right time may provide a relatively inexpensive means to lessen the burden of Alzheimer’s,” stated lead researcher, Professor Julie Zissimopoulos.
More clinical trials need to be conducted before any link between statins and lowered risk of dementia is considered a possibility but the researchers of the study are hopeful that they have revealed a potential answer to a debilitating problem. Until then, diet and exercise is recommended to fight off dementia as effectively as possible.